ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P2.01-19 Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2019.08.1363
◽
2019
◽
Vol 14
(10)
◽
pp. S646
◽
Cited By ~ 1
Author(s):
C. Ocampo
◽
J. Wu
◽
J. Dey
◽
Z. Sun
◽
M. Motwani
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Cancer Trial
◽
Phase 2 Study
◽
Previously Treated
Download Full-text
Related Documents
Cited By
References
Bortezomib ± docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): A phase 2 study
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.7034
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 7034-7034
◽
Cited By ~ 23
Author(s):
M. P. Fanucchi
◽
F. Fossella
◽
P. Fidias
◽
R. B. Natale
◽
R. J. Belt
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Previously Treated Patients
◽
Previously Treated
Download Full-text
Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2017.11.131
◽
2018
◽
Vol 13
(4)
◽
pp. 576-584
◽
Cited By ~ 29
Author(s):
Enriqueta Felip
◽
Fabrice Barlesi
◽
Benjamin Besse
◽
Quincy Chu
◽
Leena Gandhi
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Previously Treated
◽
Hsp 90
Download Full-text
Comment on ‘Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer’—No support for de-escalation of immunotherapy
European Journal of Cancer
◽
10.1016/j.ejca.2019.04.011
◽
2019
◽
Vol 115
◽
pp. 24-26
Author(s):
Alexandros Georgiou
◽
Anna Minchom
◽
Mary O'Brien
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Previously Treated
Download Full-text
P47.02 EV-202: Phase 2 Study of Enfortumab Vedotin for Previously Treated Advanced Solid Tumors Including Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.08.495
◽
2021
◽
Vol 16
(10)
◽
pp. S1096-S1097
Author(s):
K. Muro
◽
J. Yang Bruce
◽
J. Baranda
◽
T. Feinstein
◽
X. Li
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Solid Tumors
◽
Cell Lung Cancer
◽
Small Cell
◽
Advanced Solid Tumors
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Previously Treated
Download Full-text
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
European Journal of Cancer
◽
10.1016/j.ejca.2018.11.028
◽
2019
◽
Vol 108
◽
pp. 120-128
◽
Cited By ~ 15
Author(s):
Benjamin P. Levy
◽
Giuseppe Giaccone
◽
Benjamin Besse
◽
Enriqueta Felip
◽
Marina Chiara Garassino
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Previously Treated
Download Full-text
Phase 2 study of cryptophycin 52 ( LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer
Lung Cancer
◽
10.1016/s0169-5002(02)00511-1
◽
2003
◽
Vol 39
(2)
◽
pp. 197-199
◽
Cited By ~ 71
Author(s):
M Edelman
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Platinum Based Chemotherapy
◽
Phase 2 Study
◽
Previously Treated
◽
Cryptophycin 52
Download Full-text
A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
Journal of Thoracic Oncology
◽
10.1097/jto.0b013e3181aba89f
◽
2009
◽
Vol 4
(8)
◽
pp. 1002-1009
◽
Cited By ~ 39
Author(s):
Thomas J. Lynch
◽
David Fenton
◽
Vera Hirsh
◽
David Bodkin
◽
Edward L. Middleman
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
◽
Previously Treated
◽
Randomized Phase 2
Download Full-text
Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717969276.793473915
◽
2013
◽
Cited By ~ 1
Author(s):
Sam Janes
◽
Laura Succony
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717969276.793468807
◽
2013
◽
Author(s):
Thomas Stinchcombe
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
P82.02 Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2021.01.1193
◽
2021
◽
Vol 16
(3)
◽
pp. S651-S652
Author(s):
J. Beal
◽
D. Gomes
◽
P. Taranto
◽
L. Koch
◽
A.C. Rezende
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Early Stage
◽
Small Cell
◽
Stereotactic Ablative Radiotherapy
◽
Phase 2
◽
Small Cell Lung
◽
Phase 2 Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close